Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action
Diabetes Spectrum · 01.02.2024 · 37 (1) · 9-19
DOI: 10.2337/dsi23-0010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Spectrum, online erschienen am 15.02.2024. Verfasst von Zobair M Younossi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, VA; The Global NASH Council, Washington, DC, and the Center for Outcome…. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The prevalence of nonalcoholic fatty liver disease (NAFLD) in the United States is 38%, having increased by 50% within the past 3 decades. The estimated NAFLD prevalence among people with type 2 diabetes is 55–70%. The presence of type 2 diabetes is associated with a higher likelihood of progression of NAFLD to fibrosis development, liver transplant, and death. Cardiovascular disease is the main cause of mortality among people with NAFLD, and the risk of death is significantly higher in people with both NAFLD and type 2 diabetes. NAFLD carries high patient and economic burdens but low awareness among both the general public and health care providers. This article reviews the epidemiology of NAFLD and discusses the need for appropriate risk stratification, referral for specialty care, management of cardiometabolic risk factors, and treatment of the disease. The authors present a call to action to raise awareness of NAFLD and address its increasing burden in a systematic and efficient manner.
Autor:innen und Institutionen
- Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, VA; The Global NASH Council, Washington, DC, and the Center for Outcomes Research in Liver Diseases, Washington, DC.
ORCID-Profile: Zobair M Younossi
Zitieren
APA
Younossi, Z. M., & Henry, L. (2024). Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action. Diabetes Spectrum, 37(1), 9-19. https://doi.org/10.2337/dsi23-0010
Vancouver
Younossi ZM, Henry L. Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action. Diabetes Spectrum. 2024;37(1):9-19. doi:10.2337/dsi23-0010
BibTeX
@article{Younossi2024,
author = {Younossi, Zobair M and Henry, Linda},
title = {Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action},
journal = {Diabetes Spectrum},
year = {2024},
volume = {37},
number = {1},
pages = {9--19},
doi = {10.2337/dsi23-0010}
}
EUVIMED